Longer and Shorter Forms of Sendai Virus C Proteins Play Different Roles in Modulating the Cellular Antiviral Response

ABSTRACT The Sendai virus (SeV) C gene codes for a nested set of four C proteins that carry out several functions, including the modulation of viral RNA synthesis and countering of the cellular antiviral response. Using mutant C genes (and in particular a C gene with a deletion of six amino acids present only in the larger pair of C proteins) and recombinant SeV carrying these mutant C genes, we find that the nested set of C proteins carry out a nested set of functions. All of the C proteins interdict interferon (IFN) signaling to IFN-stimulated genes (ISGs) and prevent pY701-Stat1 formation. However, only the larger C proteins can induce STAT1 instability, prevent IFN from inducing an antiviral state, or prevent programmed cell death. Remarkably, interdiction of IFN signaling to ISGs and the absence of pY701-Stat1 formation did not prevent IFN-α from inducing an anti-Vesicular stomatitis virus (VSV) state. It is possible that IFN-α signaling to induce an anti-VSV state can occur independently of the well-established Jak/Stat/ISGF3 pathway and that it is this parallel pathway that is targeted by the longer C proteins.

[1]  S. Goodbourn,et al.  Sendai Virus and Simian Virus 5 Block Activation of Interferon-Responsive Genes: Importance for Virus Pathogenesis , 1999, Journal of Virology.

[2]  D. Garcin,et al.  A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy‐back nondefective interfering virus. , 1995, The EMBO journal.

[3]  D. Kolakofsky,et al.  The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. , 1992, Virology.

[4]  R. Lamb,et al.  The synthesis of sendai virus polypeptides in infected cells. , 1977, Virology.

[5]  B. Jacobs,et al.  Site-directed mutagenic analysis of reovirus sigma 3 protein binding to dsRNA. , 1994, Virology.

[6]  D. Kolakofsky,et al.  TRANSLATIONAL GYMNASTICS ON THE SENDAI VIRUS P/C MRNA , 1998 .

[7]  C. Orvell,et al.  The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. , 1982, Journal of immunology.

[8]  R. Compans,et al.  The short Sendai virus leader region controls induction of programmed cell death. , 1998, Virology.

[9]  Y. Nagai,et al.  Sendai virus C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replication and pathogenesis , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[10]  Aseem Kumar,et al.  Defective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases , 1997 .

[11]  L. Roux,et al.  The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA , 1993, Journal of virology.

[12]  K. Takeuchi,et al.  Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon-alpha/beta-mediated responses. , 1999, FEBS letters.

[13]  D. Valenzuela,et al.  Single amino acid changes that render human IFN‐alpha 2 biologically active on mouse cells. , 1987, The EMBO journal.

[14]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[15]  D. Kolakofsky,et al.  Sendai Virus Y Proteins Are Initiated by a Ribosomal Shunt , 1998, Molecular and Cellular Biology.

[16]  S. Kim,et al.  The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[17]  S. Goodbourn,et al.  The beta-interferon promoter responds to priming through multiple independent regulatory elements. , 1994, The Journal of biological chemistry.

[18]  S. Goodbourn,et al.  STAT1 Is Inactivated by a Caspase* , 1998, The Journal of Biological Chemistry.

[19]  Y. Nagai,et al.  The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis , 1997, The EMBO journal.

[20]  H. Hotta,et al.  Increased Induction of Apoptosis by a Sendai Virus Mutant Is Associated with Attenuation of Mouse Pathogenicity , 1998, Journal of Virology.

[21]  Y. Nagai,et al.  Versatility of the Accessory C Proteins of Sendai Virus: Contribution to Virus Assembly as an Additional Role , 2000, Journal of Virology.

[22]  D. Kolakofsky,et al.  An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication , 1995, Journal of virology.

[23]  D. Garcin,et al.  Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. , 1997, Virology.

[24]  H. Hotta,et al.  Isolation of an avirulent mutant of Sendai virus with two amino acid mutations from a highly virulent field strain through adaptation to LLC-MK2 cells. , 1997, The Journal of general virology.

[25]  D. Kolakofsky,et al.  Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins , 1997, Journal of virology.

[26]  B. Jacobs,et al.  Site-Directed Mutagenic Analysis of Reovirus σ3 Protein Binding to dsRNA , 1994 .

[27]  D. Kolakofsky,et al.  The Various Sendai Virus C Proteins Are Not Functionally Equivalent and Exert both Positive and Negative Effects on Viral RNA Accumulation during the Course of Infection , 1998, Journal of Virology.

[28]  D. Garcin,et al.  Sendai Virus C Proteins Counteract the Interferon-Mediated Induction of an Antiviral State , 1999, Journal of Virology.

[29]  K. Takeuchi,et al.  Sendai Virus Blocks Alpha Interferon Signaling to Signal Transducers and Activators of Transcription , 2000, Journal of Virology.

[30]  G. Stark,et al.  How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.

[31]  A. Aguzzi,et al.  Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.

[32]  D. Garcin,et al.  Partial characterization of a Sendai virus replication promoter and the rule of six. , 1996, Virology.

[33]  D. Garcin,et al.  A point mutation in the Sendai virus accessory C proteins attenuates virulence for mice, but not virus growth in cell culture. , 1997, Virology.

[34]  M. Malim,et al.  Evidence for a newly discovered cellular anti-HIV-1 phenotype , 1998, Nature Medicine.

[35]  C. Schindler.  STATs as activators of apoptosis. , 1998, Trends in cell biology.

[36]  S. Goodbourn,et al.  The V Protein of Simian Virus 5 Inhibits Interferon Signalling by Targeting STAT1 for Proteasome-Mediated Degradation , 1999, Journal of Virology.

[37]  D. Garcin,et al.  Sendai Virus C Proteins Must Interact Directly with Cellular Components To Interfere with Interferon Action , 2000, Journal of Virology.

[38]  K. Takeuchi,et al.  Knockout of the Sendai virus C gene eliminates the viral ability to prevent the interferon‐α/β‐mediated responses , 1999 .

[39]  Sheila M. Thomas,et al.  Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5 , 1988, Cell.

[40]  D. Kolakofsky,et al.  An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation. , 1994, Virology.

[41]  D. Kolakofsky,et al.  A stuttering model for paramyxovirus P mRNA editing. , 1990, The EMBO journal.

[42]  D. Garcin,et al.  The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion , 1996, Journal of virology.

[43]  J. Curran.  Reexamination of the Sendai virus P protein domains required for RNA synthesis: a possible supplemental role for the P protein. , 1996, Virology.

[44]  R. Flavell,et al.  Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis , 1997, Molecular and cellular biology.

[45]  D. Trono.  When accessories turn out to be essential , 1998, Nature Medicine.